The RESOLUTE Phase III trial of AstraZeneca’s Fasenra (benralizumab), despite showing numerical improvement, did not achieve statistical significance in the primary endpoint in patients with chronic ...
NAV STABILISES IN Q2 AS CONTINUED STRONG TRADING OFFSETS WIDER SOFTWARE MULTIPLE CONTRACTION London, 14 September 2026: ...
SEATTLE–(BUSINESS WIRE)– Amazon.com, Inc. (NASDAQ: AMZN) today announced financial results for its fourth quarter ended December 31, 2025. “AWS growing 24% (our fastest growth in 13 quarters), ...
New presentation offers convenient administration of GSK’s shingles vaccine GSK plc (LSE/NYSE: GSK) today announced Japan’s ...
Anpario plc (AIM:ANP), the independent manufacturer of natural sustainable animal feed additives for animal health, nutrition ...
Exceptionally strong order momentum, with Group order intake increasing 110% to £46.9m, already matching the FY25 order ...
UK markets saw marginal gains this week, with the FTSE 100 Index rising 0.2% to 10,830 points at the time of writing.
“HICL” or “the Company” and, together with its subsidiaries, “the Group”, the London-listed infrastructure investment company managed by InfraRed Capital Partners Limited (“InfraRed” or the ...
Commenting on the results, Chris Meredith, Chief Executive Officer of AMS, said: “I am proud to report that we have delivered on our key strategic objectives for 2025. The strength of our expanded ...
GAAP net income in the fiscal second quarter was $6.0 billion or $3.14 per share, an increase of 32% and 36%, respectively, over prior year’s results. Current year’s results included a special item of ...
UK markets were flat this week, with the FTSE 100 Index rising by 0.6% to 10,810 points at the time of writing. HM Revenue & ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results